Prism Medical And Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.11 Cr
as on 23-10-2024
- Paid Up Capital ₹ 1.10 Cr
as on 23-10-2024
- Company Age 14 Year, 29 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.15 Cr
as on 23-10-2024
- Satisfied Charges ₹ 1.40 Cr
as on 23-10-2024
- Revenue -0.88%
(FY 2023)
- Profit 94.03%
(FY 2023)
- Ebitda 3.24%
(FY 2023)
- Net Worth 8.73%
(FY 2023)
- Total Assets 16.64%
(FY 2023)
About Prism Medical And Pharmacy
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.11 Cr and a paid-up capital of Rs 1.10 Cr.
The company currently has active open charges totaling ₹7.15 Cr. The company has closed loans amounting to ₹1.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sauraj Gautam, Praneet Gautam, and Madhulika Gautam serve as directors at the Company.
- CIN/LLPIN
U24230CT2010PTC022180
- Company No.
022180
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Nov 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Company Details
- Location
Raipur, Chattisgarh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Prism Medical And Pharmacy?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sauraj Gautam  | Director | 29-Mar-2016 | Current |
| Praneet Gautam | Additional Director | 18-Apr-2013 | Current |
| Madhulika Gautam | Additional Director | 01-Sep-2011 | Current |
Financial Performance and Corporate Structure Insights of Prism Medical And Pharmacy.
Prism Medical And Pharmacy Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.88% decrease. The company also saw a substantial improvement in profitability, with a 94.03% increase in profit. The company's net worth moved up by a moderate rise of 8.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prism Medical And Pharmacy?
In 2023, Prism Medical And Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Jun 2024 | ₹3.50 Cr | Open |
Hdfc Bank Limited Creation Date: 16 Feb 2023 | ₹3.65 Cr | Open |
Others Creation Date: 27 Feb 2021 | ₹1.40 Cr | Satisfied |
How Many Employees Work at Prism Medical And Pharmacy?
Prism Medical And Pharmacy has a workforce of 9 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prism Medical And Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prism Medical And Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
